CirChem (CIRCHE) Q1 2025 earnings summary

Executive summary

• Achieved strongest Q1 to date with net sales up 82% year-over-year and EBIT loss reduced by over 60%.

• Strategic progress with new contracts in the automotive sector and successful pilots in paint and component industries.

• Focused on building recurring revenue streams and long-term partnerships for business stability.

• Investments in capacity, new office, laboratory, and AI-driven process optimization underway.

Financial highlights

• Net sales reached 4,550 tkr (2,506 tkr), up 82% compared to Q1 2024.

• EBIT improved to -1,206 tkr (-3,144 tkr), a 62% improvement year-over-year.

• EBITDA was -926 tkr (-3,112 tkr); net result per share -0.04 SEK (-0.12 SEK).

• Cash flow for the period was -3,607 tkr; cash and equivalents at period end were 8,321 tkr.

• Equity ratio increased to 75.7% (57.4%).

Outlook and guidance

• Expectation of new commercial agreements and deepening customer relationships during 2025.

• Short-term goal is positive cash flow and break-even at the Vargön facility.

• Medium-term target: 25,000 tons annual capacity and 15% EBITDA margin at 250 MSEK revenue.